You are here

Article Text

Article menu
Download PDFPDF
Clinical and epidemiological research
Concise report
Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinaemia vasculitis
  1. Guillaume Geri1,2,
  2. Benjamin Terrier1,2,
  3. Oren Semoun3,
  4. David Saadoun1,2,
  5. Damien Sène1,2,
  6. Frédéric Charlotte4,
  7. Hélène Merle-Béral5,
  8. Lucile Musset6,
  9. Matthieu Resche-Rigon3,
  10. Patrice Cacoub1,2
  1. 1Service de Médecine Interne II, Hôpital Pitié Salpetriere, Assistance Publique-Hôpitaux de Paris, Paris, France
  2. 2CNRS UMR 7211 Université Pierre et Marie Curie, Paris, France
  3. 3Département d'Informatique Médicale et de Biostatistiques, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France
  4. 4Service d'Anatomo-Pathologie, Hôpital Pitié Salpetriere, Assistance Publique-Hôpitaux de Paris, Paris, France
  5. 5Service d'Hématologie Biologique, Hôpital Pitié Salpetriere, Assistance Publique-Hôpitaux de Paris, Paris, France
  6. 6Service d'immunochimie, Hôpital Pitié-Salpétrière, Assistance Publique-Hôpitaux de Paris, Paris, France
  1. Correspondence to Patrice Cacoub, Service de Médecine Interne Hôpital La Pitié-Salpêtrière, 47–83 Boulevard de l'Hôpital, 75651 Cedex 13, Paris, France; patrice.cacoub{at}psl.aphp.fr

Abstract

Objective To evaluate clinical and biological surrogate markers associated with the presence of B cell non-Hodgkin's lymphoma (B-NHL) in patients with hepatitis C virus (HCV) with mixed cryoglobulinaemia (MC) vasculitis.

Methods A total of 104 patients with HCV-MC vasculitis (including 20 with B-NHL) were included. The main clinical and biological markers associated with the presence of B-NHL were evaluated.

Results Patients with B-NHL compared to those without showed higher rates of poor general status (40% vs 16.7%; p=0.032), purpura (90% vs 66.7%; p=0.05), renal (50% vs 28.6%; p=0.11) and cardiac involvement (15% vs 0%; p=0.0006), higher cryoglobulin levels (1.44 g/litre vs 0.67 g/litre; p=0.0004), and lower C4 (0.025 g/litre vs 0.06 g/litre; p=0.001) and γ-globulin levels (5.3 g/litre vs 13.3 g/litre; p<0.0001). The free light chain κ/λ ratio was more frequently abnormal in patients with than without B-NHL (64.3% vs 33.3%, p=0.10). On multivariate analysis, only γ-globulin level was associated with the presence of B-NHL (OR 0.77 (95% CI −0.44 to −0.13), p=0.0006). The optimal cut-off value for γ-globulin level was 9 g/litre, with sensitivity, specificity, positive and negative predictive values for the presence of B-NHL of 75%, 82%, 50% and 93%, respectively.

Conclusions In patients with HCV-MC, a low γ-globulin level (<9 g/litre) is strongly associated with the presence of B-NHL.

http://dx.doi.org/10.1136/ard.2010.132001

Statistics from Altmetric.com

    View Full Text

    Footnotes

    • GG and BT contributed equally to this work.

    • Ethics approval This study was conducted with the approval of the Hôpital Pitié Salpetriere.

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions